106 related articles for article (PubMed ID: 1906126)
1. Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver.
Cox IJ; Coutts GA; Gadian DG; Ghosh P; Sargentoni J; Young IR
Magn Reson Med; 1991 Jan; 17(1):53-61. PubMed ID: 1906126
[TBL] [Abstract][Full Text] [Related]
2. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.
Menon DK; Sargentoni J; Taylor-Robinson SD; Bell JD; Cox IJ; Bryant DJ; Coutts GA; Rolles K; Burroughs AK; Morgan MY
Hepatology; 1995 Feb; 21(2):417-27. PubMed ID: 7843715
[TBL] [Abstract][Full Text] [Related]
3. Phosphorus-31 magnetic resonance spectroscopy of the human liver using chemical shift imaging techniques.
Cox IJ; Menon DK; Sargentoni J; Bryant DJ; Collins AG; Coutts GA; Iles RA; Bell JD; Benjamin IS; Gilbey S
J Hepatol; 1992 Mar; 14(2-3):265-75. PubMed ID: 1323598
[TBL] [Abstract][Full Text] [Related]
4. [31P-MR spectroscopy of liver diseases with reference to variable pulse recovery times].
Brinkmann G; Melchert UH; Lalk G; Heller M
Rofo; 1993 Nov; 159(5):412-8. PubMed ID: 8219133
[TBL] [Abstract][Full Text] [Related]
5. Relationship of 31P MR spectroscopy to the histopathological grading of chronic hepatitis and response to therapy.
Kiyono K; Shibata A; Sone S; Watanabe T; Oguchi M; Shikama N; Ichijo T; Kiyosawa K; Sodeyama T
Acta Radiol; 1998 May; 39(3):309-14. PubMed ID: 9571950
[TBL] [Abstract][Full Text] [Related]
6. Non-alcoholic fatty liver disease: spectral patterns observed from an in vivo phosphorus magnetic resonance spectroscopy study.
Abrigo JM; Shen J; Wong VW; Yeung DK; Wong GL; Chim AM; Chan AW; Choi PC; Chan FK; Chan HL; Chu WC
J Hepatol; 2014 Apr; 60(4):809-15. PubMed ID: 24291241
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of biochemical metabolites by 31P MR spectroscopy in leukemic infiltration of liver].
Sun JZ; Wang ZK; Yu RS; Huang LS; Xu XF; Zhang MM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Mar; 39(2):150-6. PubMed ID: 20387242
[TBL] [Abstract][Full Text] [Related]
8. In vivo hepatic 31P magnetic resonance spectroscopy in chronic alcohol abusers.
Menon DK; Harris M; Sargentoni J; Taylor-Robinson SD; Cox IJ; Morgan MY
Gastroenterology; 1995 Mar; 108(3):776-88. PubMed ID: 7875480
[TBL] [Abstract][Full Text] [Related]
9. Phosphorus magnetic resonance spectroscopy in malformations of cortical development.
Andrade CS; Otaduy MC; Valente KD; Maia DF; Park EJ; Valério RM; Tsunemi MH; Leite CC
Epilepsia; 2011 Dec; 52(12):2276-84. PubMed ID: 21973076
[TBL] [Abstract][Full Text] [Related]
10. Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient.
Bashir A; Gropler R; Ackerman J
PLoS One; 2015; 10(12):e0143239. PubMed ID: 26633549
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive quantitation of human liver metabolites using image-guided 31P magnetic resonance spectroscopy.
Meyerhoff DJ; Karczmar GS; Matson GB; Boska MD; Weiner MW
NMR Biomed; 1990 Feb; 3(1):17-22. PubMed ID: 2390449
[TBL] [Abstract][Full Text] [Related]
12. Malignant hepatic tumors: P-31 MR spectroscopy with one-dimensional chemical shift imaging.
Francis IR; Chenevert TL; Gubin B; Collomb L; Ensminger W; Walker-Andrews S; Glazer GM
Radiology; 1991 Aug; 180(2):341-4. PubMed ID: 1648755
[TBL] [Abstract][Full Text] [Related]
13. Alcoholic liver disease: quantitative image-guided P-31 MR spectroscopy.
Meyerhoff DJ; Boska MD; Thomas AM; Weiner MW
Radiology; 1989 Nov; 173(2):393-400. PubMed ID: 2798871
[TBL] [Abstract][Full Text] [Related]
14. Metabolic profile of liver damage in non-cirrhotic virus C and autoimmune hepatitis: A proton decoupled
Hakkarainen A; Puustinen L; Kivisaari R; Boyd S; Nieminen U; Arkkila P; Lundbom N
Eur J Radiol; 2017 May; 90():205-211. PubMed ID: 28583636
[TBL] [Abstract][Full Text] [Related]
15. The response of the rat liver in situ to bromobenzene--in vivo proton magnetic resonance imaging and 31P magnetic resonance spectroscopy studies.
Locke SJ; Brauer M
Toxicol Appl Pharmacol; 1991 Sep; 110(3):416-28. PubMed ID: 1949010
[TBL] [Abstract][Full Text] [Related]
16. Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.
Norén B; Lundberg P; Ressner M; Wirell S; Almer S; Smedby O
Eur Radiol; 2005 Jan; 15(1):148-57. PubMed ID: 15351899
[TBL] [Abstract][Full Text] [Related]
17. The total entropy for evaluating 31P-magnetic resonance spectra of the liver in healthy volunteers and patients with metastases.
Brinkmann G; Melchert UH; Lalk G; Emde L; Link J; Muhle C; Steffens JC; Heller M
Invest Radiol; 1997 Feb; 32(2):100-4. PubMed ID: 9039582
[TBL] [Abstract][Full Text] [Related]
18. A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states.
Wylezinska M; Cobbold JF; Fitzpatrick J; McPhail MJ; Crossey MM; Thomas HC; Hajnal JV; Vennart W; Cox IJ; Taylor-Robinson SD
NMR Biomed; 2011 Apr; 24(3):231-7. PubMed ID: 20949641
[TBL] [Abstract][Full Text] [Related]
19. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
[TBL] [Abstract][Full Text] [Related]
20. Decreased phosphorus metabolite concentrations and alkalosis in chronic cerebral infarction.
Sappey-Marinier D; Hubesch B; Matson GB; Weiner MW
Radiology; 1992 Jan; 182(1):29-34. PubMed ID: 1727305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
